设为首页 加入收藏

TOP

ZINCFRIN®-A ophthalmic solution
2014-10-03 14:25:02 来源: 作者: 【 】 浏览:801次 评论:0
ZINCFRIN®-A ophthalmic solution

SCHEDULING STATUS:

S2

PROPRIETARY NAME
(and dosage form):

ZINCFRIN®-A ophthalmic solution

COMPOSITION:
Zinc sulfate 1,25mg,
Antazoline phosphate 5,0mg,
Naphazoline hydrochloride 0,5mg per mL,
Preserved with benzethonium chloride 0,01%.

PHARMACOLOGICAL CLASSIFICATION:
A.15.4 Ophthalmic preparations, other.

PHARMACOLOGICAL ACTION:
A combination of a vasoconstrictor and an antihistamine for the relief of ocular symptoms due to allergy and inflammation of a non-infectious origin. Zinc sulfate is incorporated in the formulation as a mild astringent.

INDICATIONS:
Symptomatic relief to tearing, photophobia, redness, swelling, blepharospasm and itching due to allergies. Also, it may be used to control hyperemia of the palpebral and bulbar conjunctiva resulting from bacterial, allergic and vernal conjunctivitis.

CONTRA-INDICATIONS:
Narrow angle glaucoma.

DOSAGE AND DIRECTIONS FOR USE:
Instil 2drops in the eye(s) every 3to 4hours, or as prescribed.
Note: Keep container tightly closed.
Do not touch dropper tip to any surface since this may contaminate the solution.

SIDE EFFECTS AND SPECIAL PRECAUTIONS:
Prolonged use of a decongestant may result in rebound congestion.
Discontinue use when it is no longer needed to control symptoms. If symptoms persist or increase, discontinue use and consult a physician.
In rare instances individual idiosyncrasies are manifested. These appear as very mild stinging and inflammation following instillation.
Should sensitivity or other untoward reactions occur, discontinue medication. Do not use solution if discoloured.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
None recorded.

IDENTIFICATION:
A clear, colourless to pale yellow solution.

PRESENTATION:
Drop-Tainer™ containing 15mL.

STORAGE INSTRUCTIONS:
Store in a cool place, below 25°C, protected from light.
KEEP OUT OF REACH OF CHILDREN.

REGISTRATION NUMBER:
F/15.4/116

NAME AND BUSINESS ADDRESS OF THE APPLICANT:
Alcon Laboratories (S.A.) (Pty) Ltd.
Surrey Avenue
RANDBURG. 2194

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
14 May 1974

0990VL 34284-E
342844 
以下是“全球医药”详细资料
Tags: 责任编辑:admin
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇VITAFORCE NUTRI-B tablets 下一篇LAXADOR BISACODYL TABLETS

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位